Certified by Founder Lodge
Psylo
Australia - Sydney, NSW
START UP
1 Disclosed Funding Rounds $8,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Psylo is a drug development company focused on next generation psychedelics; our goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, u
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 04 ,2024 | Seed | $8,000,000 |
Mystic Ventures
Focalpoint Partners
Palo Santo
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
WealthAi | $1,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
